ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 110 filers reported holding ARBUTUS BIOPHARMA CORP in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,604 | -11.7% | 6,209 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $14,281 | -24.1% | 6,209 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $18,813 | +22.5% | 6,209 | -5.8% | 0.00% | 0.0% |
| Q4 2022 | $15,362 | +22.0% | 6,593 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $12,593 | +154.6% | 6,593 | +261.3% | 0.00% | – |
| Q2 2022 | $4,946 | -70.4% | 1,825 | -67.5% | 0.00% | -100.0% |
| Q1 2022 | $16,715 | -77.5% | 5,609 | -70.7% | 0.00% | 0.0% |
| Q4 2021 | $74,420 | -23.7% | 19,131 | -15.8% | 0.00% | 0.0% |
| Q3 2021 | $97,503 | -19.3% | 22,728 | +77.7% | 0.00% | -50.0% |
| Q3 2018 | $120,866 | – | 12,790 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COWEN AND COMPANY, LLC | 4,331,020 | $7,882,000 | 1.31% |
| RTW INVESTMENTS, LP | 6,869,281 | $12,502,000 | 0.35% |
| A.R.T. Advisors, LLC | 14,140 | $26,000 | 0.04% |
| Hudson Bay Capital Management LP | 975,000 | $1,774,000 | 0.03% |
| Secure Asset Management, LLC | 10,000 | $18,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,774,935 | $3,230,000 | 0.01% |
| FNY Investment Advisers, LLC | 9,900 | $18,000 | 0.01% |
| Squarepoint Ops LLC | 322,225 | $586,000 | 0.01% |
| LMR Partners LLP | 107,912 | $196,000 | 0.01% |
| Virtu Financial LLC | 17,147 | $31,000 | 0.00% |